Olenec Christopher MD Sarasota, FL - 34239

Olenec Christopher MD is categorized under Internal Medicine Doctors in Sarasota, FL and active since 2010.

Olenec Christopher MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Christopher Olenec at the company’s single location by writing to 2089 Hawthorne St # 200, Sarasota, Florida FL 34239 or by phoning (941) 365-6556. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Olenec Christopher MD
Contact Person: Christopher Olenec
Address: 2089 Hawthorne St # 200, Sarasota, Florida 34239
Phone Number: (941) 365-6556
Website Address: suncoastendoscopy.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Olenec Christopher MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Christopher Olenec for inquiries that concern Olenec Christopher MD by calling the company number (941) 365-6556, as your correspondence is most welcome. Additionally, the physical location of the single location of Olenec Christopher MD can be found at the coordinates 27.31831,-82.52835 as well as the street address 2089 Hawthorne St # 200 in Sarasota, Florida 34239.

For its online presence, you may visit Olenec Christopher MD’s website at suncoastendoscopy.com and engage with its social media outlets through on Twitter and on Facebook.